Skip to main content

Propel Bio Management, LLC

SEC CIK
0001969764
Latest filing
Aug 13, 2026

CRNX holding history

Crinetics Pharmaceuticals, Inc. in every 13F filed by Propel Bio Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRNX overviewAll 13F holders of CRNXFull Q2 2026 holdings

Shares (Q1 2024)
0
Sold out in Q1 2024
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q4 2023
Holdings of CRNX by Propel Bio Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20240$00.0%−165,000−100.0%Sold outHolders
Q4 2023165,000$5.87M4.9%–No prior filingHolders